Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Kardan Terug naar discussie overzicht

Kardan ruzie met obligatiehouders

4 Posts
| Omlaag ↓
  1. forum rang 10 DeZwarteRidder 21 november 2017 13:46
    LETTER FROM THE DEBENTURE HOLDERS
    Amsterdam, November 21, 2017 – Kardan N.V. (‘Kardan’ or ‘the Company’), active in Real Estate and Water Infrastructure in emerging markets, announces it received a letter from the representatives of the trustee of debenture holders series B (‘the Trustee’). In this letter, the debenture holders of series B claim that the financial situation of the Company has deteriorated since the date of signing the deeds of trust of the debentures in July 2015 (‘the Deeds of Trust’ and ‘the 2015 Debt Settlement’), which, in their view, places the Company in breach based on the terms and definitions of article 43 to the Deeds of Trust. Therefore series B debenture holders claim that the balance payments between the debentures of series A and series B, as defined in article 43 to the Deeds of Trust, should be implemented and that the Company should be making payments to repay debentures series B before making any payments to debenture holders of series A, due to an expected immediate repayment and the implication of the said article 43.
    The letter include various claims regarding the deterioration in the financial position of the Company compared to 2015, and the right of debenture holders B to ask for immediate repayment, as follows:

    - The Trustee claims that according to the press release dated 13.11.2017, the Company approached the debenture holders to enter into discussions with a view to reach certain agreements with respect to amendments to the Deeds of Trust, also in relation to the timetables of making payments to the debenture holders. According to the Trustee, this publication affirms the significant concerns the Trustee has warned about and it should be regarded as an announcement of the Company that it will not be able to meet its obligations as they fall due.

    - The Trustee claims that there are many additional signs that point out significant deterioration since the 2015 Debt Settlement, including: mandatory emphasis of matter in its financial statements since June 2017; weak liquidity in the immediate and expected term which is reflected in a decrease of the cash balances of the Company; significant decrease in the equity of the Company; decrease in the values of the assets securing the debentures; downgrading of the rating of the Company to ilCCC; and the fact that the debentures are traded at high yield.

    - The Trustee claims that the assets of the Company in China, especially the mall in Dalian, did not meet the expectations of increase in value and even decreased by 10%. In this respect it is further claimed by the Trustee that based on the reported information on the mall there are indications that the situation is worse than presented by the Company, in relation to the forecasted revenues, NOI and the negative operating cash flow despite increase in occupancy rates.

    - In addition, the Trustee claims that according to initial professional advice he received, it appears that the valuation of the shopping mall in Dalian is based on parameters which are too optimistic, wrong or not relevant, in relation to the forecasted revenues, occupancy rates, increase in rental revenues and the comparable assets, and therefore the realistic value of the mall is significantly lower than the value presented in the financial statements of the Company, and therefore, the Trustee claims that the external appraiser should have made a higher impairment in its valuation report. Furthermore, the Trustee claims that the valuation should have assumed immediate sale of the asset and not in 11 years.

    - It is also claimed that according to checks performed by the Trustee, selling real estate assets in China is a very complicated and is not certain with respect to consideration and timing. In addition the holding structure of the assets in China should be taken into consideration (which, according to the Trustee, makes a sale difficult and decreases the net consideration to the Company)
    - The Trustee claims that the assumption in the cash flow forecast of the Company to obtain €120 million in 2018 is not substantiated. The Trustee also claims that even if the Company
    will receive such amount, this will require the sale of assets in a manner that will not beneficiate the Company and its creditors, under distress sale assumptions.

    Under these circumstances, the Trustee claims that according to the Deeds of Trust, Debenture Holders B have the right to call the debt for immediate repayment.
    The Company is examining the claims detailed in the letter and the requests elaborated in the letter and their potential implications. Without derogating from the aforesaid, the Company is of the opinion that there is no base to the claims detailed in the letter regarding the value of shopping mall in Dalian.
  2. forum rang 10 DeZwarteRidder 21 november 2017 16:02
    Als ik de brief van Trustee nog eens goed lees, dan kom ik tot de conclusie dat ze maar een ding willen en dat is beslag leggen op de gehele opbrengst van de verkoop van Tahal (ipv alleen de verplichte aflossing) en dat ze heel goed begrijpen dat een gedwongen verkoop van Tahal en Dalian niet in hun belang is.
    Bovendien is er blijkbaar een soort conflict tussen de A en B obligatiehouders.
  3. forum rang 10 DeZwarteRidder 21 november 2017 16:38
    Obligatiehouders kunnen onderpand opeisen.

    (ABM FN-Dow Jones) Als obligatiehouders dat verlangen, moet Kardan binnen zeven dagen alle lopende verplichtingen versneld afbetalen en zijn obligatiehouders machtigen om het onderpand op te eisen. Dat blijkt uit de trustakte die Kardan in 2015 sloot met zijn schuldeisers.
    Kardan meldde dinsdag een brief te hebben gekregen van obligatiehouders, waarin zij het recht op directe terugbetaling claimden.
    Het aandeel daalde daarop met 19 procent, nadat het een dag eerder nog met 40 procent was gestegen.
    Volgens de trustakte mag de curator die optreedt namens de obligatiehouders directe terugbetaling claimen "als er een substantiële verslechtering optreedt" in de bedrijven van Kardan na het sluiten van de trustakte en als er volgens de curator reële zorg is dat de B-obligaties bijtijds worden terugbetaald. Dit waren precies de redenen die de curator in zijn brief aanvoerde om het recht te claimen. De curator mag na die stap ook juridische procedures starten tegen Kardan, om de rechten van de obligatiehouders af te dwingen.

    In een reactie tegen ABM Financial News stelde Kardan dinsdag in gesprek te zullen met zijn obligatiehouders en daarover te zullen rapporteren. Het bedrijf zegt "zich niet bewust te zijn van enige directe implicaties" van de stap van de obligatiehouders om het recht op directe terugbetaling te claimen.

    Volgens Kardan claimen de obligatiehouders op dit moment dat obligatiehouders van serie B, die nog 150 miljoen euro aan schuld hebben uitstaan, voorrang moeten krijgen op obligatiehouders van serie A-stukken, die nog zo'n 49 miljoen euro tegoed hebben, exclusief rente.

    Door: ABM Financial News.
    info@abmfn.nl
    Redactie: +31(0)20 26 28 999
    Copyright ABM Financial News. All rights reserved
    (END) Dow Jones Newswires
    November 21, 2017 10:30 ET (15:30 GMT)
    © 2017 ABM Financial News. All rights reserved.
4 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.287
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.503
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.962
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.531
Aedifica 2 832
Aegon 3.257 320.120
AFC Ajax 537 7.018
Affimed NV 2 5.763
ageas 5.843 109.779
Agfa-Gevaert 13 1.864
Ahold 3.536 73.985
Air France - KLM 1.024 34.359
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.583
Allfunds Group 3 1.217
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 338
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.767
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.390
AMG 965 125.933
AMS 3 73
Amsterdam Commodities 303 6.524
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.168
Apollo Alternative Assets 1 17
Apple 5 320
Arcadis 251 8.624
Arcelor Mittal 2.024 318.687
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.114
Aroundtown SA 1 177
Arrowhead Research 5 9.283
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.718
ASML 1.762 77.115
ASR Nederland 18 4.125
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.686
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 07 mei

    1. Japan inkoopmanagersindex diensten april
    2. NL inflatie april
    3. Reserve Bank of Australia rentebesluit
    4. Infineon Q1-cijfers
    5. UBS Q1-cijfers
    6. Zalando Q1-cijfers
    7. Solvay Q1-cijfers
    8. Heijmans Q1-cijfers
    9. Kendrion Q1-cijfers
    10. BP Q1-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht